ARCH Venture Partners — 2016 Investments
4 investments dated 2016 · listed companies and verified rows first · show all
Quanterix develops technology for highly sensitive detection of protein biomarkers using non-invasive sample types, aimed at early disease detection and prevention.
BiotechDigital HealthHealthtechMedical DevicesLexington, US
John Connolly(Director)Douglas Cole(Director)David Walt(Director)Martin Madaus(Director)Dennis Sandstedt(Director)Ernest Orticerio(Executive Officer)
Board seatKeith Crandell· per SEC Form D
Agrivida develops enzyme technology for animal feed and nutrition, improving efficiency in poultry, swine, and other livestock production.
AgTechBiotechFoodTechMassachusetts, US
Rob Johnson(Director)R. Michael Raab(Executive Officer)Daniel Meagher(Executive Officer, Director)Mark Austin(Director)Robert Bucklin(Director)Jeremy Schley Johnson(Executive Officer)
Board seatClinton Bybee· per SEC Form D
Brisbane, US
Board seatRobert NelsenKristina Burow· per SEC Form D
LifeMine is a biopharmaceutical company that uses data science and advanced methods to accelerate drug discovery and develop precision medicines across therapeutic areas.
AI & Machine LearningBiotechDeep TechCambridge, US
Gregory L. Verdine(Executive Officer, Director)Hingge Hsu(Executive Officer, Director)Weiqing Zhou(Executive Officer, Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.